Overbrook Management Corp Neurocrine Biosciences Inc Transaction History

Overbrook Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $708,924 - $883,647	-8,157 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $23,078 - $32,436	-240 Reduced 2.86%	8,157 $784,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $714,500 - $1.09 Million	8,397 New	8,397 $1.02 Million

635

93.5M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

Stay updated on Overbrook Management Corp with notifications on news.